Relay Therapeutics Inc
RLAY
ISIN null / Valor 55675918
Relay Therapeutics Inc
UMushroom community rating:
About company
Relay Therapeutics Inc is a biotechnology company focused on drug discovery and development by leveraging its proprietary Dynamo platform, which combines advanced computational and experimental techniques to analyze protein dynamics. By understanding the motion and function of proteins, Relay aims to identify and target previously intractable protein targets, facilitating the creation of precision therapies for conditions such as cancer and genetic disorders. The company’s approach seeks to overcome challenges in traditional drug development, enabling the design of more effective and specific therapeutic interventions.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
2590 M
Market cap (USD)
6,071,418
Daily traded volume (Shares)
4.3 / 4.165
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
